Skip to main content
2009 search results for:

Cancer care 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 06-02-2023 | Breast cancer | News | Article

    Disparities exist in care of breast cancer patients from minority sexual orientation, gender groups

    US research points to disparities in the diagnosis, treatment, and outcomes of breast cancer in people belonging to minority groups with respect to sexual orientation and gender identity.

  2. 28-04-2022 | Patient-reported outcomes | News | Article
    guidelinesWatch

    ESMO provides recommendations on use of PROMs in cancer care

    medwireNews : ESMO has issued a Clinical Practice Guideline on using patient-reported outcome measures (PROMs) during the care of people with cancer.

  3. 26-07-2021 | Prostate cancer | News | Article

    Care of Black prostate cancer patients disproportionately affected during COVID-19

    Black men with nonmetastatic prostate cancer were significantly less likely than their White counterparts to undergo prostatectomy during the initial wave of the COVID-19 pandemic, reports a US research team.

  4. 01-06-2021 | COVID-19 | News | Article

    Cancer care in India hit widely by COVID-19

    Delivery of all aspects of cancer care fell by between 23% and 54% in India at the start of the COVID-19 pandemic, compared with the same period in 2019, show data published in The Lancet Oncology .

  5. 31-03-2021 | Survival | News | Article

    Worse cancer outcomes in areas of deprivation transcend access to quality care

    Researchers have identified an association between socioeconomic deprivation and poor survival in people with cancer participating in clinical trials.

  6. 18-03-2020 | Lung cancer | Podcast | Article

    COVID-19 and cancer patient care: A lung cancer specialist’s experience

    Gilberto Lopes discusses the impact of the COVID-19 pandemic on the management of patients with lung cancer and outlines the measures being implemented to minimize the risk for patients.

  7. 27-11-2020 | COVID-19 | News | Article

    Cancer patients report changes in care during pandemic

    One in three people with cancer experienced changes to their care in the early months of the COVID-19 pandemic, according to a survey of the Dutch PROFILES registry participants.

  8. 10-11-2020 | Breast cancer | News | Article

    Major impact of COVID-19 pandemic on breast cancer care reported

    A survey of Italian breast cancer units has highlighted the severe impact of the global SARS-CoV-2 outbreak on the management of individuals with breast cancer.

  9. 12-05-2020 | Comorbidities | News | Article
    News in brief

    ESMO releases patient guide for cancer care during COVID-19 pandemic

    ESMO has issued guidance for patients with cancer on the possible impact of COVID-19 on their care.

  10. 30-05-2020 | ASCO 2020 | News | Article

    Maintenance avelumab ‘new standard of care’ for advanced urothelial cancer

    The JAVELIN Bladder 100 trial has shown a significant improvement in the overall survival of advanced urothelial cancer patients with the addition of avelumab to best supportive care in the maintenance setting.

  11. 04-10-2023 | Adverse events | News | Article

    High incidence of alpelisib‐associated hyperglycemia in routine care

    A retrospective analysis has found a significantly higher incidence of hyperglycemia among breast cancer patients treated with alpelisib in standard care than on clinical trials.

  12. 26-10-2023 | Toxicities | Teaser

    Looking for coverage of ESMO 2023?

    There's a new home for news and congress coverage! Catch up on all the top stories and latest evidence in oncology research with our ESMO congress hub page.  Learn more »

  13. 21-05-2020 | Breast cancer | News | Article

    monarcHER points to chemotherapy-free care for HR-, HER2-positive advanced breast cancer

    Women with hormone receptor-positive, HER2-positive locally advanced, metastatic, or recurrent breast cancer might benefit from a third- or later-line regimen of the CDK4/6 inhibitor abemaciclib in combination with trastuzumab and fulvestrant, findings from the phase 2 monarcHER trial suggests.

  14. 20-10-2023 | Prostate cancer | News | Article

    Enzalutamide use supported for biochemically recurrent prostate cancer

    Men with localized prostate cancer and high-risk biochemical recurrence benefit from treatment with enzalutamide, either alongside leuprolide or alone.

  15. 06-10-2023 | Prostate cancer | News | Article

    Add-on SBRT improves outcomes of men with oligometastatic CRPC

    Patients with oligometastatic castration-resistant prostate cancer benefit from the addition of stereotactic body radiotherapy to first-line abiraterone acetate plus prednisone.

  16. 22-09-2023 | KRAS inhibitors | News | Article

    Novel KRAS inhibitor elicits ‘durable responses’ in KRAS G12C mutation-positive tumors

    They were aged a median of 65 years and 60 had non-small-cell lung cancer (NSCLC), while 55 had colorectal cancer (CRC) and 22 had other solid tumors.

  17. 29-09-2023 | Adverse events | News | Article

    Trial adds to evidence for risk-based thromboprophylaxis in people with cancer

    Findings from the TARGET-TP trial support a risk-directed approach to thromboprophylaxis in ambulatory patients with gastrointestinal or lung cancer receiving systemic anticancer treatment.

  18. 13-09-2023 | Immunotherapy | News | Article

    Cutaneous irAEs tied to improved survival after ICI treatment

    A meta-analysis has shown that cutaneous immune-related adverse events are prognostic for improved survival among people with cancer receiving immune checkpoint inhibitor therapy.

  19. 08-09-2023 | Non-small-cell lung cancer | News | Article

    Add-on tumor treating fields boost metastatic NSCLC survival

    medwireNews : Supplementing standard systemic therapy with tumor treating fields (TTFields) prolongs the overall survival (OS) of previously treated patients with metastatic non-small-cell lung cancer (NSCLC), show phase 3 trial data.

  20. 30-08-2023 | COVID-19 | News | Article

    Cancer treatment linked to increased risk for COVID-19-related VTE

    Gulati et al also identified other factors significantly associated with an elevated risk for VTEs, such as history of VTE, active or progressing cancer, and high-risk site of cancer (aRRs=3.10, 1.43, and 1.42 respectively).

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.